BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25777981)

  • 1. PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma.
    Cui Z; Song L; Hou Z; Han Y; Hu Y; Wu Y; Chen W; Mao L
    Oncol Rep; 2015 May; 33(5):2454-60. PubMed ID: 25777981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of JARID1B expression inhibits cell proliferation, induces apoptosis and blocks cell cycle in human acute lymphoblastic leukemia cells.
    Huang YQ; Zou Y; Zheng RJ; Ma XD
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1366-1373. PubMed ID: 29565495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the transcription repressor PLU-1/JARID1B.
    Scibetta AG; Santangelo S; Coleman J; Hall D; Chaplin T; Copier J; Catchpole S; Burchell J; Taylor-Papadimitriou J
    Mol Cell Biol; 2007 Oct; 27(20):7220-35. PubMed ID: 17709396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma.
    Sun LL; Sun XX; Xu XE; Zhu MX; Wu ZY; Shen JH; Wu JY; Huang Q; Li EM; Xu LY
    Acta Histochem; 2013 Jan; 115(1):56-62. PubMed ID: 22534467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel read-through transcript JMJD7-PLA2G4B regulates head and neck squamous cell carcinoma cell proliferation and survival.
    Cheng Y; Wang Y; Li J; Chang I; Wang CY
    Oncotarget; 2017 Jan; 8(2):1972-1982. PubMed ID: 28030848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.
    Catchpole S; Spencer-Dene B; Hall D; Santangelo S; Rosewell I; Guenatri M; Beatson R; Scibetta AG; Burchell JM; Taylor-Papadimitriou J
    Int J Oncol; 2011 May; 38(5):1267-77. PubMed ID: 21369698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases.
    Barrett A; Santangelo S; Tan K; Catchpole S; Roberts K; Spencer-Dene B; Hall D; Scibetta A; Burchell J; Verdin E; Freemont P; Taylor-Papadimitriou J
    Int J Cancer; 2007 Jul; 121(2):265-75. PubMed ID: 17373667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
    Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
    Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.
    Facompre ND; Harmeyer KM; Sole X; Kabraji S; Belden Z; Sahu V; Whelan K; Tanaka K; Weinstein GS; Montone KT; Roesch A; Gimotty PA; Herlyn M; Rustgi AK; Nakagawa H; Ramaswamy S; Basu D
    Cancer Res; 2016 Sep; 76(18):5538-49. PubMed ID: 27488530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.
    Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K
    Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma.
    Zhang J; An X; Han Y; Ma R; Yang K; Zhang L; Chi J; Li W; Llobet-Navas D; Xu Y; Jiang Y
    Cell Death Dis; 2016 Sep; 7(9):e2358. PubMed ID: 27584795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression.
    Shen X; Zhuang Z; Zhang Y; Chen Z; Shen L; Pu W; Chen L; Xu Z
    Tumour Biol; 2015 Sep; 36(9):7133-42. PubMed ID: 25877751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of JARID1B siRNA on proliferation and apoptosis in HL-60 cell].
    Ma XD; Han HD; Huang YQ; Zou Y
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):392-6. PubMed ID: 22781799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis.
    Cameron S; de Long LM; Hazar-Rethinam M; Topkas E; Endo-Munoz L; Cumming A; Gannon O; Guminski A; Saunders N
    Mol Cancer; 2012 Sep; 11():74. PubMed ID: 23021083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.
    Su H; Ma X; Huang Y; Han H; Zou Y; Huang W
    Int J Clin Exp Pathol; 2015; 8(1):171-83. PubMed ID: 25755704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.
    Li P; Bian XY; Chen Q; Yao XF; Wang XD; Zhang WC; Tao YJ; Jin R; Zhang L
    PLoS One; 2017; 12(5):e0177484. PubMed ID: 28494008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3.
    Wang W; Zheng K; Pei Y; Zhang X
    Oncol Res; 2018 Apr; 26(3):373-384. PubMed ID: 28492139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
    Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
    J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.